Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

Emma Wall(UCL Biomedical Research Centre), Mary Wu(The Francis Crick Institute), Ruth Harvey(The Francis Crick Institute), Gavin Kelly(The Francis Crick Institute), Scott Warchal(The Francis Crick Institute), Chelsea Sawyer(The Francis Crick Institute), Rodney S. Daniels(The Francis Crick Institute), Philip Hobson(The Francis Crick Institute), Emine Hatipoglu(University College London), Yenting Ngai(University College London), Saira Hussain(The Francis Crick Institute), Jérôme Nicod(The Francis Crick Institute), Robert Goldstone(The Francis Crick Institute), Karen Ambrose(The Francis Crick Institute), Steve Hindmarsh(The Francis Crick Institute), Rupert Beale(University College London), Andrew Riddell(The Francis Crick Institute), Steve Gamblin(The Francis Crick Institute), Michael Howell(The Francis Crick Institute), George Kassiotis(Imperial College London), Vincenzo Libri(UCL Biomedical Research Centre), Bryan Williams(National Institute for Health Research), Charles Swanton(The Francis Crick Institute), Sonia Gandhi(University College London), David L.V. Bauer(The Francis Crick Institute)
The Lancet
June 1, 2021
10.1016/s0140-6736(21)01290-3
Cited by 558Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis